We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-14%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$43.7M
AUM Growth
-$11.6M
Cap. Flow
-$2M
Cap. Flow %
-4.57%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TBIO
Telesis Bio, Inc. Common Stock
TBIO
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$430M
$15.9M 36.46%
3,255,426
– –
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
$14.3M 32.82%
4,214,498
– –
CADL icon
3
Candel Therapeutics
CADL
$689M
$13.4M 30.72%
1,935,215
– –
TBIO
4
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
– –
-546,897
Closed -$2M

Similar funds

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Northpond Ventures's Q3 2024 Portfolio in Review

As of Q3 2024, Northpond Ventures held 4 positions worth $43.7M, down 21% from $55.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Northpond Ventures withdrew a net $2M in Q3 2024, closing 1 position. Its most notable exit was Telesis Bio, Inc. Common Stock, an estimated $2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures fully exited Telesis Bio, Inc. Common Stock in Q3 2024, selling an estimated $2M.
  • Northpond Ventures's ten largest holdings make up 100% of its $43.7M portfolio in Q3 2024.
  • Northpond Ventures opened 0 new positions and closed 1 in Q3 2024.
  • Northpond Ventures's portfolio value fell 21% quarter-over-quarter to $43.7M.

Based on Northpond Ventures's 13F filing for Q3 2024, filed 14 Nov 2024.